Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.Prolocor was founded in 2020 and is based in Philadelphia, PA.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 16, 2022 | Seed | $3.20M | 1 | — | — | Detail |